04/08/2026
Clinical Trial Summit of Pakistan CTSP 2026 Day 1 | 3 August 2026
As a leading clinical research organization CRO in Pakistan, Dimension Research is committed to advancing clinical research excellence through innovation, collaboration, and capacity building. During CTSP 2026, Dimension Research shared perspectives on the evolving landscape of healthcare innovation and the growing role of clinical research in bringing advanced therapies to patients.
The Day 1 session, presented by Mr. Khurram Khurram Zaki Khan, CEO Dimension Resarch CRO & SMO focused on Next Generation Therapies and its impact on the future of medicine. The presentation explored emerging therapeutic approaches, advancements in precision medicine, and the critical role of clinical trials in evaluating innovative treatments. The session also highlighted the opportunities and challenges associated with adopting next-generation therapies and the importance of strengthening Pakistan's clinical research ecosystem to support these advancements.
Dimension Research CRO & SMO also proudly showcased its services at CTSP 2026, highlighting its expertise in clinical trial management, regulatory support, site management, and research operations while engaging with healthcare and research professionals.
Dimension Research believe in promoting knowledge exchange, encourages innovation, and take pride in contributing to the continued growth of a high-quality clinical research environment in Pakistan.